PI
IMGN

PEAK6 Investments’s Immunogen Inc IMGN Stock Holding History

PEAK6 Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58,900
Closed -$1.75M – 4926
2023
Q4 		$1.75M Buy
58,900
+10,500
+22% +$209K 0.01% 1633
2023
Q3 		$768K Buy
48,400
+300
+0.6% +$4.99K ﹤0.01% 2031
2023
Q2 		$908K Buy
+48,100
New +$568K ﹤0.01% 1777
2022
Q3 		– Sell
-48,100
Closed -$908K – 6383
2022
Q2 		$908K Buy
+48,100
New +$209K ﹤0.01% 3205

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PEAK6 Investments's IMGN Position: Q4 2023 in Review

PEAK6 Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 4,527 shares — an estimated $90.1K sold.

PEAK6 Investments first reported a position in IMGN in Q1 2023 and held it in 2 quarters. The position peaked at $76.8K in Q1 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • PEAK6 Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 4,527 Immunogen Inc shares in Q4 2023, an estimated $90.1K.
  • PEAK6 Investments first reported a position in Immunogen Inc in Q1 2023 and held it in 2 quarters.
  • PEAK6 Investments's Immunogen Inc position peaked at $76.8K in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.